Raymond J. Henley Iii

Array ( [id] => 6413219 [patent_doc_number] => 20020183290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Adrenergic receptor antagonists selective for both alpha1A-and alpha1D-subtypes and uses therefor' [patent_app_type] => new [patent_app_number] => 10/060925 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15493 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183290.pdf [firstpage_image] =>[orig_patent_app_number] => 10060925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1307363 [patent_doc_number] => 06617322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-09 [patent_title] => 'Preferentially substituted calcium channel blockers' [patent_app_type] => B2 [patent_app_number] => 10/060900 [patent_app_country] => US [patent_app_date] => 2002-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6986 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617322.pdf [firstpage_image] =>[orig_patent_app_number] => 10060900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7454370 [patent_doc_number] => 20040068009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Systemic formulations containing beta-carotene and derivatives thereof' [patent_app_type] => new [patent_app_number] => 10/466825 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7366 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20040068009.pdf [firstpage_image] =>[orig_patent_app_number] => 10466825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048745 [patent_doc_number] => 20020169195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Combination and method of treatment of cancer utilizing a COX-2 inhibitor and an HMG-CoA inhibitor and cystine to enhance glutathione' [patent_app_type] => new [patent_app_number] => 10/057511 [patent_app_country] => US [patent_app_date] => 2002-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18734 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169195.pdf [firstpage_image] =>[orig_patent_app_number] => 10057511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792540 [patent_doc_number] => 20030087884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Use of low dose amount of spironolactone for treatment of cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/054799 [patent_app_country] => US [patent_app_date] => 2002-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5901 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087884.pdf [firstpage_image] =>[orig_patent_app_number] => 10054799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291621 [patent_doc_number] => 20040110849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Anti-atherosclerosis composition containing carotenoids and method for inhibiting ldl oxidation' [patent_app_type] => new [patent_app_number] => 10/466957 [patent_app_country] => US [patent_app_date] => 2004-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 2128 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110849.pdf [firstpage_image] =>[orig_patent_app_number] => 10466957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987604 [patent_doc_number] => 20020099075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => new [patent_app_number] => 10/052320 [patent_app_country] => US [patent_app_date] => 2002-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11905 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099075.pdf [firstpage_image] =>[orig_patent_app_number] => 10052320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7349473 [patent_doc_number] => 20040047894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Preparation for improved dietary utilisation' [patent_app_type] => new [patent_app_number] => 10/250567 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6325 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047894.pdf [firstpage_image] =>[orig_patent_app_number] => 10250567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416790 [patent_doc_number] => 06521644 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Compositions for promoting growth' [patent_app_type] => B1 [patent_app_number] => 09/937031 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2958 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521644.pdf [firstpage_image] =>[orig_patent_app_number] => 09937031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543911 [patent_doc_number] => 07166625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Method for treating fibrotic diseases and other indications' [patent_app_type] => utility [patent_app_number] => 10/037447 [patent_app_country] => US [patent_app_date] => 2001-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21970 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166625.pdf [firstpage_image] =>[orig_patent_app_number] => 10037447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1333653 [patent_doc_number] => 06596744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-22 [patent_title] => 'Method for treating fibrotic diseases or other indications IIC' [patent_app_type] => B2 [patent_app_number] => 10/038116 [patent_app_country] => US [patent_app_date] => 2001-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13324 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1096 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596744.pdf [firstpage_image] =>[orig_patent_app_number] => 10038116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1240087 [patent_doc_number] => 06686354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Agonists and antagonists of peripheral-type benzodiazepine receptors' [patent_app_type] => B2 [patent_app_number] => 10/033189 [patent_app_country] => US [patent_app_date] => 2001-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15927 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686354.pdf [firstpage_image] =>[orig_patent_app_number] => 10033189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740815 [patent_doc_number] => 20030158184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses' [patent_app_type] => new [patent_app_number] => 10/024040 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 20567 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158184.pdf [firstpage_image] =>[orig_patent_app_number] => 10024040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786296 [patent_doc_number] => 20020159983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Bioprosthetic heart valves' [patent_app_type] => new [patent_app_number] => 10/032123 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11198 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20020159983.pdf [firstpage_image] =>[orig_patent_app_number] => 10032123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7453272 [patent_doc_number] => 20040067922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Pharmaceutical composition for treatment of phimosis using topical corticosteroid' [patent_app_type] => new [patent_app_number] => 10/465977 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2699 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067922.pdf [firstpage_image] =>[orig_patent_app_number] => 10465977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 761136 [patent_doc_number] => 07012072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-14 [patent_title] => 'Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same' [patent_app_type] => utility [patent_app_number] => 10/450260 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2932 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/012/07012072.pdf [firstpage_image] =>[orig_patent_app_number] => 10450260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440494 [patent_doc_number] => 20020128319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Abeta 42 lowering agents' [patent_app_type] => new [patent_app_number] => 10/012606 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19933 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128319.pdf [firstpage_image] =>[orig_patent_app_number] => 10012606 [rel_patent_id] =>[rel_patent_doc_number] =>)